Passage Bio Appoints Thomas Kassberg to Leadership Team
PremiumCompany AnnouncementsPassage Bio Appoints Thomas Kassberg to Leadership Team
2M ago
Passage Bio initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Passage Bio initiated with a Buy at Rodman & Renshaw
2M ago
Passage Bio Presents Updated Corporate Insights
Premium
Company Announcements
Passage Bio Presents Updated Corporate Insights
3M ago
Passage Bio received positive feedback in Type C meeting with FDA on PBFT02
PremiumThe FlyPassage Bio received positive feedback in Type C meeting with FDA on PBFT02
4M ago
Passage Bio price target lowered to $13 from $14 at Canaccord
Premium
The Fly
Passage Bio price target lowered to $13 from $14 at Canaccord
6M ago
Passage Bio Unveils Updated Corporate Presentation
Premium
Company Announcements
Passage Bio Unveils Updated Corporate Presentation
6M ago
New Innovation / R&D Risk for Passage Bio, Inc. – What’s the Latest?
PremiumCompany AnnouncementsNew Innovation / R&D Risk for Passage Bio, Inc. – What’s the Latest?
8M ago
Passage Bio files $200M mixed securities shelf
Premium
The Fly
Passage Bio files $200M mixed securities shelf
8M ago
Passage Bio Welcomes Kathleen Borthwick as New CFO
Premium
Company Announcements
Passage Bio Welcomes Kathleen Borthwick as New CFO
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100